No evidence of an association of ERCC1 and ERCC2 polymorphisms with clinical outcomes of platinum-based chemotherapies in non-small cell lung cancer: a meta-analysis

Por Yin, Ming, Yan, Jingrong, Voutsina, Alexandra, Tibaldi, Carmelo, Christiani, David C., Heist, Rebecca S., Rosell, Rafael, Booton, Richard, Wei, Qingyi
Publicado em 2010

microRNA classifiers are powerful diagnostic/prognostic tools in ALK-, EGFR-, and KRAS-driven lung cancers

Por Gasparini, Pierluigi, Cascione, Luciano, Landi, Lorenza, Carasi, Stefania, Lovat, Francesca, Tibaldi, Carmelo, Alì, Greta, D’Incecco, Armida, Minuti, Gabriele, Chella, Antonio, Fontanini, Gabriella, Fassan, Matteo, Cappuzzo, Federico, Croce, Carlo M.
Publicado no Proc Natl Acad Sci U S A (2015)

EGFR and K-Ras mutations in women with lung adenocarcinoma: implications for treatment strategy definition

Por Rotella, Virginia, Fornaro, Lorenzo, Vasile, Enrico, Tibaldi, Carmelo, Boldrini, Laura, Chella, Antonio, D’Incecco, Armida, Cirigliano, Giovanna, Chioni, Aldo, Lupi, Cristiana, Sensi, Elisa, Ginocchi, Laura, Giovannelli, Simona, Pennucci, Maria Cristina, Fontanini, Gabriella, Baldini, Editta
Publicado em 2014